Laennec

Laennec has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Jan 1, 2026: “Recent Perspectives on the Physiological and Therapeutic Benefits of Placental Extracts in Chronic Noninfectious Diseases and Aging”.

Intervention

1 paper studies it1 findingUpdated

  • 1 lab in 1 country

What did studies of Laennec find?

1

Studies of Laennec measured 1 outcome; the most studied are hepatic fibrosis (1 study).

Hepatic fibrosis

downin reviews1

1 study
  1. Laennec decreases hepatic fibrosis.

    “Laennec and porcine extracts improved iron metabolism, reduced hepatic fibrosis, and enhanced glucose regulation in type 2 diabetes and non-alcoholic fatty liver disease.”

    Reviewtype 2 diabetes and non-alcoholic fatty liver disease

    Recent Perspectives on the Physiological and Therapeutic Benefits of Placental Extracts in Chronic Noninfectious Diseases and Aging

    Current medicinal chemistry

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 paper in 12 months